Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer receiving first‐line immunotherapy.

Autor: Zheng, Xixi1 (AUTHOR), Zhou, Lili1 (AUTHOR), Shi, Hui1 (AUTHOR), An, Juan1 (AUTHOR), Xu, Weiran1 (AUTHOR), Ding, Xiaosheng1 (AUTHOR), Hua, Yichun1 (AUTHOR), Shi, Weiwei2 (AUTHOR) shiweiwei301@sina.com, Li, Xiaoyan1 (AUTHOR) sharerha@126.com
Zdroj: Thoracic Cancer. Oct2024, Vol. 15 Issue 28, p2029-2037. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje